Michelle Cheng

Palo Alto University — United States

Neuroscience · Life Sciences

28h-index4.0kcitations123works1.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Photoreceptor and optogenetics research(22), Moyamoya disease diagnosis and treatment(16), Neuroinflammation and Neurodegeneration Mechanisms(13), Neurological Disease Mechanisms and Treatments(12), Cerebrovascular and genetic disorders(11)

Publications123 total

Abstract DP199: Rapid vascular glycocalyx loss and complement activation drive blood-brain barrier disruption in hyperglycemic stroke
Stroke·2026
Abstract DP349: Optogenetic Neuronal Stimulation Modulates Cholesterol Dynamics in Post-Stroke Recovery
Stroke·2026
Abstract TP380: Distinct Immune Cell Signatures and Intercellular Signaling in Moyamoya Disease
Stroke·2026
Abstract TP274: Spatial RNA Transcriptome Analysis of Moyamoya Disease Intracranial Arteries
Stroke·2026
Institutional partnerships: results from a scoping review of promising strategies to promote diversity within the academic health sciences
BMC Medical Education·2025Open Access
Luminal Vascular Dysfunction Drives Rapid Blood Brain Barrier Injury in Hyperglycemic Stroke: Key Roles for Luminal Glycocalyx and Complement
2025Open Access
Community Health Workers Research: Where Are We Now? A Narrative Review of an Expanding Workforce for Mental Health
Harvard Review of Psychiatry·2025· 2 cited
Abstract WMP113: Investigating Cholesterol Dynamics in Post-Stroke Recovery through Optogenetic Neuronal Stimulation
Stroke·2025
Abstract TP346: Investigating Transcriptomic Profiles of Peripheral Blood Mononuclear Cells in Moyamoya Disease Using Single-Cell RNAseq
Stroke·2025
Abstract WP385: Impact of estrous cycle hormones on optogenetic stimulation and stroke recovery dynamics
Stroke·2025· 1 cited
Abstract TP374: Spleen Immune Cell Changes in Stroke and Hyperglycemia: Insights from Flow Cytometry
Stroke·2025
Abstract TMP11: Imaging-Based Approach To The Pathophysiology Of Moyamoya Disease Among Diverse Ethnicities
Stroke·2025
Abstract TP382: Genome-wide DNA Methylation Profiling Reveals Low Methylation Variability in Moyamoya Disease
Stroke·2025
Advances in moyamoya disease: pathogenesis, diagnosis, and therapeutic interventions
MedComm·2025· 18 citedOpen Access
Genome-Wide DNA Methylation Profiling Reveals Low Methylation Variability in Moyamoya Disease
Translational Stroke Research·2024· 7 citedOpen Access
Industry Perceptions and Experiences with the Access Consortium New Active Substance Work-Sharing Initiative (NASWSI): Survey Results and Recommendations
Therapeutic Innovation & Regulatory Science·2024· 2 citedOpen Access
A Learning Assessment to Increase Diversity in Academic Health Sciences
JAMA Health Forum·2024· 5 citedOpen Access
Abstract WMP115: Rapid Vascular Complement Activation: A Key Driver of Blood-Brain Barrier Disruption in Ischemic Stroke With Acute Hyperglycemia
Stroke·2024
Abstract TP284: Transcriptome Profiling of Peripheral Blood Mononuclear Cells in Moyamoya Disease
Stroke·2024
Abstract WMP118: Utilizing Patient-Derived Induced Pluripotent Stem Cells as a Cellular Model for Studying Moyamoya Disease
Stroke·2024
page 1 of 7Next →

Frequent Co-authors

Gary K. Steinberg(18), Alex G. Lee(11), Qun‐Yong Zhou(7), Heng Zhao(7), Robert M. Sapolsky(7), Eric H. Wang(6), Emanual Maverakis(6), Frances M. Leslie(5), Guohua Sun(5), Rong Xie(4), S. Lévy(4), Zhijuan Cao(4), Terrance Chiang(4), Elizabeth A. Wang(4), Arjun V. Pendharkar(4), Jia‐Da Li(3), Markus Aswendt(3), David M. Lyons(3), Shunsuke Ishizaka(3), Daniel Smerin(3)